摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-[3-((6aS,10S,10aS,11aR)-8-carbamoyl-10-dimethylamino-4,6,6a,9-tetrahydroxy-5,7-dioxo-5,6a,7,10,10a,11,11a,12-octahydro-naphthacen-1-yl)-benzoylamino]-propionic acid ethyl ester | 1035975-91-7

中文名称
——
中文别名
——
英文名称
3-[3-((6aS,10S,10aS,11aR)-8-carbamoyl-10-dimethylamino-4,6,6a,9-tetrahydroxy-5,7-dioxo-5,6a,7,10,10a,11,11a,12-octahydro-naphthacen-1-yl)-benzoylamino]-propionic acid ethyl ester
英文别名
——
3-[3-((6aS,10S,10aS,11aR)-8-carbamoyl-10-dimethylamino-4,6,6a,9-tetrahydroxy-5,7-dioxo-5,6a,7,10,10a,11,11a,12-octahydro-naphthacen-1-yl)-benzoylamino]-propionic acid ethyl ester化学式
CAS
1035975-91-7
化学式
C33H35N3O10
mdl
——
分子量
633.655
InChiKey
PYZVTJRSBJMDLW-HTYHEQNISA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.47
  • 重原子数:
    46.0
  • 可旋转键数:
    8.0
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.36
  • 拓扑面积:
    216.79
  • 氢给体数:
    6.0
  • 氢受体数:
    11.0

反应信息

点击查看最新优质反应信息

文献信息

  • Substituted Tetracycline Compounds
    申请人:Kim Oak K.
    公开号:US20100305072A1
    公开(公告)日:2010-12-02
    The present invention pertains, at least in part, to novel substituted tetracycline compounds. These tetracycline compounds can be used to treat numerous tetracycline compound-responsive states, such as bacterial infections and neoplasms.
    本发明至少部分涉及新型替代四环素化合物。这些四环素化合物可用于治疗许多对四环素化合物敏感的疾病状态,如细菌感染和肿瘤。
  • SUBSTITUTED TETRACYCLINE COMPOUNDS
    申请人:PARATEK PHARMACEUTICALS, INC.
    公开号:US20160046561A1
    公开(公告)日:2016-02-18
    The present invention pertains, at least in part, to novel substituted tetracycline compounds. These tetracycline compounds can be used to treat numerous tetracycline compound-responsive states, such as bacterial infections and neoplasms.
    本发明至少部分涉及新型取代四环素化合物。这些四环素化合物可用于治疗许多对四环素化合物敏感的疾病状态,如细菌感染和肿瘤。
  • Tetracycline derivatives for the treatment of bacterial, viral and parasitic infections
    申请人:Paratek Pharmaceuticals, Inc.
    公开号:EP2455367A1
    公开(公告)日:2012-05-23
    The present invention pertains, at least in part, to novel substituted tetracycline compounds. These tetracycline compounds can be used to treat numerous tetracycline compound-responsive states, such as bacterial infections and neoplasms.
    本发明至少部分涉及新型取代的四环素化合物。这些四环素化合物可用于治疗多种四环素化合物反应状态,如细菌感染和肿瘤。
  • TETRACYCLINE DERIVATIVES FOR THE TREATMENT OF BACTERIAL, VIRAL AND PARASITIC INFECTIONS
    申请人:Paratek Pharmaceuticals, Inc.
    公开号:EP3045449A1
    公开(公告)日:2016-07-20
    The present invention pertains to tetracycline derivatives. These tetracycline derivatives can be used to treat numerous tetracycline compound-responsive states, such as bacterial infections and neoplasms, viral and parasitic infections as well as inflammatory disorders, such as inflammatory disorders caused by radiation or trauma and inflammatory conditions of the skin.
    本发明涉及四环素生物。这些四环素生物可用于治疗多种四环素化合物反应状态,如细菌感染和肿瘤、病毒和寄生虫感染以及炎症性疾病,如辐射或创伤引起的炎症性疾病和皮肤炎症。
  • 7-HETEROCYCLYL SUBSTITUTED SANCYCLINE DERIVATIVES FOR TREATING BACTERIAL, VIRAL AND PARASITIC INFECTIONS (E.G. MALARIA) OR INFLAMMATORY DISEASES
    申请人:Paratek Pharmaceuticals, Inc.
    公开号:EP3812372A2
    公开(公告)日:2021-04-28
    The present invention relates to tetracycline derivatives, and in particular to sancycline derivatives substituted at their 7-position by a five-membered heterocyclic ring, for use in the treatment of bacterial, viral and/or parasitic infections, such as e.g. malaria, and/or inflammatory diseases.
    本发明涉及四环素生物,特别是在其 7 位上被五元杂环取代的仙环素衍生物,用于治疗细菌、病毒和/或寄生虫感染,如疟疾和/或炎症性疾病。
查看更多